This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 13 print issues and online access
$259.00 per year
only $19.92 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Bernard JF, Besson JM. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J Neurophysiol. 1990;63:473–90.
Allen HN, Chaudhry S, Hong VM, Lewter LA, Sinha GP, Carrasquillo Y, et al. A parabrachial-to-amygdala circuit that determines hemispheric lateralization of somatosensory processing. Biol Psychiatry. 2023;93:370–81.
Torres-Rodriguez JM, Wilson TD, Singh S, Torruella-Suárez ML, Chaudhry S, Adke AP, et al. The parabrachial to central amygdala pathway is critical to injury-induced pain sensitization in mice. Neuropsychopharmacology. 2023:1–13.
Nelson TS, Sinha GP, Santos DFS, Jukkola P, Prasoon P, Winter MK, et al. Spinal neuropeptide Y Y1 receptor-expressing neurons are a pharmacotherapeutic target for the alleviation of neuropathic pain. Proc Natl Acad Sci. 2022;119:e2204515119.
Sun L, Liu R, Guo F, Wen MQ, Ma XL, Li KY, et al. Parabrachial nucleus circuit governs neuropathic pain-like behavior. Nat Commun. 2020;11:5974.
This work was supported by the National Institutes of Health awards K00NS124190 (TSN) and F32NS128392 (HNA).
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Nelson, T.S., Allen, H.N. The spino-parabrachio-amygdaloid pathway is critical for the manifestation of chronic pain. Neuropsychopharmacol. (2023). https://doi.org/10.1038/s41386-023-01745-7